Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Earle, C. C., Kulke, M. H., . . . Fuchs, C. S. (2009). Weekly docetaxel, cisplatin, and irinotecan (TPC): Results of a multicenter phase II trial in patients with metastatic esophagogastric cancer. Oxford University Press.
Chicago Stili AlıntıEnzinger, P. C., et al. Weekly Docetaxel, Cisplatin, and Irinotecan (TPC): Results of a Multicenter Phase II Trial in Patients With Metastatic Esophagogastric Cancer. Oxford University Press, 2009.
MLA AlıntıEnzinger, P. C., et al. Weekly Docetaxel, Cisplatin, and Irinotecan (TPC): Results of a Multicenter Phase II Trial in Patients With Metastatic Esophagogastric Cancer. Oxford University Press, 2009.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..